Breviscapine attenuates lead‑induced myocardial injury by activating the Nrf2 signaling pathway.

Authors:
Li D; Xu Z; Li Y; Huang Y; Yin J and 2 more

Journal:
Exp Ther Med

Publication Year: 2023

DOI:
10.3892/etm.2023.12314

PMCID:
PMC10728892

PMID:
38125346

Journal Information

Full Title: Exp Ther Med

Abbreviation: Exp Ther Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding: This study was supported by the Special Basic Cooperative Research Programs of Yunnan Provincial Undergraduate Universities' Association (grant no. 2018FH001-089) and the Fund of Research Institution in Yunnan Provincial Medical and Health Units (grant no. 2018NS0218)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025